RxDoctor Payments DataLook up a doctor →

Peter Jenkin, MD

Dermatology · Manchester, NHNPI 1922024033

Payments from drug & device makers

$1,233,744in general payments, 2019–2025

Across 731 payments — averaging $1687.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$679K
  • AbbVie$176K
  • Pfizer$112K
  • E.r. Squibb & Sons, L.L.C.$88K
  • UCB SA$60K
  • Janssen Research & Development, LLC$48K
  • plus $72K from 28 others
$31,029in research payments, 2019–2025

Across 16 payments — averaging $1939.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$25K
  • Janssen Research & Development, LLC$6K

What the payments were for

  • Consulting fees$11,39510%
  • Speaking & faculty fees$71,62561%
  • Travel & lodging$7,7917%
  • Food & beverage$13,32611%
  • Education$650%
  • Other$12,89711%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,233,744 in reported general payments places this provider in the 95th percentile of 75 dermatology providers in New Hampshire.

See all dermatology providers in New Hampshire

Medicare billing

Part B allowed, 2024
$109,527
Medicare patients
461
Services billed
2,951

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CiclopiroxCiclopirox Olamine100$1,527
Ketoconazole85$1,285
Ciclopirox28$907
Desoximetasone14$731
Clobetasol Propionate18$655
Fluocinonide11$637
Doxycycline Monohydrate14$404
Mometasone Furoate30$282
Mupirocin13$70

Paid to pharmacies, not to this prescriber.

Other dermatology in Manchester

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →